Alcohol, Drugs, and Impaired Driving


Book Description

Alcohol, Drugs, and Impaired Driving addresses many theoretical and practical issues related to the role played by alcohol and other psychoactive drugs on driving performance, road-traffic safety, and public health. Several key forensic issues are involved in the enforcement of laws regulating driving under the influence of alcohol and/or other drugs, including analytical toxicology, pharmacology of drug action, as well as the relationships between dose taken, concentration levels in the body, and impairment of performance and behavior. Our knowledge of drunken driving is much more comprehensive than drugged driving, so a large part of this book is devoted to alcohol impairment, as well as impairment caused by use of drugs other than alcohol. For convenience, the book is divided into four main sections. The first section gives some historical background about measuring alcohol in blood and breath as evidence for the prosecution of traffic offenders. The important role of the Breathalyzer instrument in traffic-law enforcement, especially in Australia, Canada, and the USA is presented along with a biographical sketch of its inventor (Professor Robert F. Borkenstein of Indiana University) with focus on the man, his work and his impact. The second section discusses several issues related to forensic blood and breath-alcohol alcohol analysis as evidence for prosecution of traffic offenders. This includes how the results should be interpreted in relation to impairment and an evaluation of common defense challenges. Because most countries have adopted concentration per se laws, the main thrust of the prosecution case is the suspect’s measured blood- or breath-alcohol concentration. This legal framework necessitates that the analytical methods used are "fit for purpose" and are subjected to rigorous quality assurance procedures. The third section gives a broad overview of the current state of knowledge about driving under the influence of non-alcohol drugs in various countries. This includes adoption of zero-tolerance laws, concentration per se statutes, and clinical evidence of driver impairment based on field sobriety tests and drug recognition expert evidence. The fourth section deals with epidemiology, enforcement, and countermeasures aimed at reducing the threat of drunken and drugged driving. All articles have appeared previously in the international journal Forensic Science Review, but all are completely updated with current data, references, and the latest research on developments since the articles were published. This book contains a convenient collection of the best articles covering recommendations for blood and breath testing methods, public policy relating to such methods, and forensic and legal implications of the enforcement of measures to counter driving under the influence.




Drugs, Driving and Traffic Safety


Book Description

Drugs, Driving and Traffic Safety gives a comprehensive overview of the effects of different medical conditions like neurological disorders, anxiety and depression and their pharmaceutical treatment on driving ability. In addition, the effects of alcohol and drugs of abuse are discussed. Leading experts present the different methodologies to examine effects of drugs on driving, and summarize the recent scientific evidence including epidemiological studies, roadside surveys, laboratory tests, driving simulators, and the standardized driving test. The volume includes guidelines of the International Council on Alcohol, Drugs and Traffic Safety (ICADTS) and the ICADTS Drugs List 2007. Drugs, Driving and Traffic Safety is written for physicians, psychiatrists and pharmacists who want to inform their patients who use psychoactive drugs.










Driving With Care: Alcohol, Other Drugs, and Impaired Driving Offender Treatment-Strategies for Responsible Living


Book Description

This is a 12-session, 24-hour education program for impaired driving offenders who have at least minimal indicators of past problems associated with AOD use or misuse and whose arrest BAC was at the impaired driving level. Level II Education helps clients to understand how problem behaviors are learned and how those behaviors are strengthened. They develop a good understanding of their involvement in impaired driving and how their state laws apply to that involvement. Clients learn how their own AOD use fits clinically identified patterns and cycles of AOD use and misuse. They develop strategies and skills to prevent future problems of use and misuse and involvement in DWI behavior: relapse and recidivism prevention.




Driving With Care:Education and Treatment of the Impaired Driving Offender-Strategies for Responsible Living


Book Description

This is a three-level education and treatment program for persons convicted of driving while impaired (DWI). Clients learn that change in behavior is made by changing their thoughts, attitudes and beliefs. The books presents a comprehensive overview of cognitive behavioral treatment for impaired driving offenders; a thorough review theory and practice related to client evaluation; legal and cultural considerations; as well as operational procedures for assessing and matching DWI offenders to appropriate levels of education and treatment services. Guidelines are provided for developing individualized treatment plans, and implementing appropriate education and treatment curriculum protocol whereby clients relate and apply the lesson and session material to their own unique circumstances and situations.




National Drug Control Strategy (1997)


Book Description

Contents: the purposes and nature of strategy (a comprehensive 10-year plan); profile of drug abusers (trends in youth drug abuse; health consequences; cost of drug-related crime; illegal drugs remain available); strategic goals and objectives (demand and supply reduction; goals and objectives; measures of effectiveness); a comprehensive approach (youth oriented initiatives; initiatives to reduce drug-related crime and violence; reduce health and social problems; shield our frontiers; reduce drug availability); and resources to implement the strategy.




Alcohol, Drugs, and Impaired Driving


Book Description

Alcohol, Drugs, and Impaired Driving addresses many theoretical and practical issues related to the role played by alcohol and other psychoactive drugs on driving performance, road-traffic safety, and public health. Several key forensic issues are involved in the enforcement of laws regulating driving under the influence of alcohol and/or other drugs, including analytical toxicology, pharmacology of drug action, as well as the relationships between dose taken, concentration levels in the body, and impairment of performance and behavior. Our knowledge of drunken driving is much more comprehensive than drugged driving, so a large part of this book is devoted to alcohol impairment, as well as impairment caused by use of drugs other than alcohol. For convenience, the book is divided into four main sections. The first section gives some historical background about measuring alcohol in blood and breath as evidence for the prosecution of traffic offenders. The important role of the Breathalyzer instrument in traffic-law enforcement, especially in Australia, Canada, and the USA is presented along with a biographical sketch of its inventor (Professor Robert F. Borkenstein of Indiana University) with focus on the man, his work and his impact. The second section discusses several issues related to forensic blood and breath-alcohol alcohol analysis as evidence for prosecution of traffic offenders. This includes how the results should be interpreted in relation to impairment and an evaluation of common defense challenges. Because most countries have adopted concentration per se laws, the main thrust of the prosecution case is the suspect’s measured blood- or breath-alcohol concentration. This legal framework necessitates that the analytical methods used are "fit for purpose" and are subjected to rigorous quality assurance procedures. The third section gives a broad overview of the current state of knowledge about driving under the influence of non-alcohol drugs in various countries. This includes adoption of zero-tolerance laws, concentration per se statutes, and clinical evidence of driver impairment based on field sobriety tests and drug recognition expert evidence. The fourth section deals with epidemiology, enforcement, and countermeasures aimed at reducing the threat of drunken and drugged driving. All articles have appeared previously in the international journal Forensic Science Review, but all are completely updated with current data, references, and the latest research on developments since the articles were published. This book contains a convenient collection of the best articles covering recommendations for blood and breath testing methods, public policy relating to such methods, and forensic and legal implications of the enforcement of measures to counter driving under the influence.




Driving with Care: Alcohol, Other Drugs, and Driving Safety Education-Strategies for Responsible Living


Book Description

This is a 12-session, 24-hour education program for impaired driving offenders who have at least minimal indicators of past problems associated with AOD use or misuse and whose arrest BAC was at the impaired driving level. Level II Education helps clients to understand how problem behaviors are learned and how those behaviors are strengthened. They develop a good understanding of their involvement in impaired driving and how their state laws apply to that involvement. Clients learn how their own AOD use fits clinically identified patterns and cycles of AOD use and misuse. They develop strategies and skills to prevent future problems of use and misuse and involvement in DWI behavior: relapse and recidivism prevention.




Clinical Geriatric Psychopharmacology


Book Description

Thoroughly updated for its Fourth Edition, this volume is the most authoritative clinical reference on the pharmacologic treatment of psychiatric disorders in elderly patients. This edition provides complete information on new psychotropic drugs, new uses for established drugs, and clinically relevant advances in the neurosciences. Four new chapters cover genes, pharmacokinetics, and their impact on prescribing; new cognitive-enhancing strategies and drugs; late-life depression and physical illness; and depression and cardiac disease in late life. The book offers detailed guidelines—including drug names, dosages, and prescribing recommendations—for pharmacologic treatment of specific disorders. Chapters include clinical vignettes and tables presenting current clinical trial data. Appendices provide succinct information on prescribing and drug interactions.